Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Liposomes
Reexamination Certificate
2007-07-24
2007-07-24
Kishore, Gollamudi S. (Department: 1615)
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Liposomes
Reexamination Certificate
active
10782738
ABSTRACT:
This invention provides methods for treating neoplasias in a mammal. In particular, the invention provides methods for treating various types of lymphomas, including relapsed forms of non-Hodgkin's Lymphoma. These methods involve the administration of liposome-encapsulated vinca alkaloids, e.g., vincristine, to a mammal with a lymphoma.
REFERENCES:
patent: 4186183 (1980-01-01), Steck et al.
patent: 4217344 (1980-08-01), Vanlerberghe et al.
patent: 4235871 (1980-11-01), Papahadjopoulos et al.
patent: 4261975 (1981-04-01), Fullerton et al.
patent: 4485054 (1984-11-01), Mezei et al.
patent: 4501728 (1985-02-01), Geho et al.
patent: 4603044 (1986-07-01), Geho et al.
patent: 4737323 (1988-04-01), Martin et al.
patent: 4774085 (1988-09-01), Fidler
patent: 4837028 (1989-06-01), Allen
patent: 4885172 (1989-12-01), Bally et al.
patent: 4946787 (1990-08-01), Eppstein et al.
patent: 4952408 (1990-08-01), Rahman
patent: 4957773 (1990-09-01), Spencer et al.
patent: 5059421 (1991-10-01), Loughrey et al.
patent: 5077056 (1991-12-01), Bally et al.
patent: 5165922 (1992-11-01), Hellstrom et al.
patent: 5171578 (1992-12-01), Bally et al.
patent: 5262168 (1993-11-01), Lenk et al.
patent: 5543152 (1996-08-01), Webb et al.
patent: 5567592 (1996-10-01), Benet et al.
patent: 5595756 (1997-01-01), Bally et al.
patent: 5714163 (1998-02-01), Forssen et al.
patent: 5736155 (1998-04-01), Bally et al.
patent: 5741516 (1998-04-01), Webb et al.
patent: 5762957 (1998-06-01), Mehlhorn
patent: 5814335 (1998-09-01), Webb et al.
patent: 5820873 (1998-10-01), Choi et al.
patent: 5837282 (1998-11-01), Fenske et al.
patent: 5885613 (1999-03-01), Holland et al.
patent: 6320017 (2001-11-01), Ansell
patent: WO 91/17424 (1991-11-01), None
Bloomfield, V., “Quasi-Elastic Light Scattering Application in Biochemistry and Biology,”Ann. Rev. Biophys. Bioeng. 10:421-450, 1981.
Deamer, D. et al., “Larger Volume Liposomes by an Ether Vaporization Method,”Biochim. et Biophys. Acta 443:629-634, 1976.
Dumontet, C. et al., “Mechanisms of Action of and Resistance to Antitubulin Agents: Microtubule Dynamics, Drug Transport, and Cell Death,”J. Clin. Oncol. 17(3):1061-1070, Mar. 1999.
Fraley, R. et al., “Entrapment of a Bacterial Plasmid in Phospholipid Vesicles: Potential for Gene Transfer,”Proc. Natl. Acad. Sci. USA 76(7):3348-3352, Jul. 1979.
Gruner, S.,Liposomes—from Biophysics to Therapeutics,Marcel Dekker, Inc., New York, Ch. 1, “Materials Properties of Liposomal Bilayers,” pp. 1-38.
Heath, T., “Covalent Attachment of Proteins to Liposomes,”Methods in Enzymology 149:111-119, 1987.
Hope, M. et al., “Production of Large Unilamellar Vesicles by a Rapid Extrusion Procedure. Characterization of Size Distribution, Trapped Volume and Ability to Maintain a Membrane Potential,”Biochem. et Biophys. Acta 812:55-65, 1985.
Hope, M. et al., “Generation of Multilamellar and Unilamellar Phospholipid Vesicles,”Chemistry and Physics of Lipids 40:89-107, 1986.
Hudson, W. et al., “Xenotransplantation of Human Lymphoid Malignancies is Optimized in Mice with Multiple Immunologic Defects,”Leukemia 12:2029-2033, 1998.
Kluin-Nelemans, H. et al., “A New Non-Hodgkin's B-Cell Line (DoHH2) with a Chromosomal Translocation t(14;18) (q32;q21),”Leukemia 5(3):221-224, Mar. 1991.
King, R.E.,Remington's Pharmaceutical Sciences,17thEd., Mack Publishing Co., Philadelphia, PA, 1985, Part 8, “Pharmaceutical Preparations and Their Manufacture,” pp. 1409-1677.
Leonetti, J-P. et al., “Antibody-Targeted Liposomes Containing Oligodeoxyribonucleotides Complementary to Viral RNA Selectively Inhibit Viral Replication,”Proc. Natl. Acad. Sci. USA 87:2448-2451, Apr. 1990.
Mayer, L. et al., “Vesicles of Variable Sizes Produced by a Rapid Extrusion Procedure,”Biochim. et Biophys. Acta 858:161-168, 1986.
Merck Index, 11thed. 1989, Entry Nos. 9887, 9891, & 9893.
Renneisen, K. et al., “Inhibition of Expression of Human Immunodeficiency Virus-1 inVitroby Antibody-Targeted Liposomes Containing Antisense RNA to theenvRegion,”J. Biol. Chem. 265(27):16337-16342, Sep. 1990.
U.S. Appl. No. 08/316,394, filed Sep. 30, 1994, Ansell.
U.S. Appl. No. 08/316,407, filed Sep. 30, 1994, Holland et al.
U.S. Appl. No. 08/996,783, filed Dec. 23, 1997, Ansell.
Szoka F., “Comparative Properties and Methods of Preparation of Lipid Vesicles (Liposomes),”Ann. Rev. Biophys. Bioeng.9:467-508, 1980.
Williams, K. et al., “Low Density Lipoprotein Receptor-Independent Hepatic Uptake of a Synthetic, Cholesterol-Scavenging Lipoprotein: Implications for the Treatment of Receptor-Deficient Atherosclerosis,”Proc. Natl. Acad. Sci. USA 85:242-246, Jan. 1988.
Burge Clive T R
Cabanillas Fernando
Goldie James H
Logan Patricia M
Sarris Andreas H
Board of Regents , The University of Texas System
Inex Pharmaceuticals Corporation
Kishore Gollamudi S.
Seed Intellectual Property Law Group PLLC
LandOfFree
Compositions and methods for treating lymphoma does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compositions and methods for treating lymphoma, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions and methods for treating lymphoma will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3800171